287 related articles for article (PubMed ID: 19712701)
41. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
[TBL] [Abstract][Full Text] [Related]
42. Cytomegalovirus UL97 ganciclovir resistance mutations in kidney transplant recipients.
Tasoujlu M; Khalafkhany D; Makhdoomi K; Motazakker M
Bratisl Lek Listy; 2022; 123(7):518-522. PubMed ID: 35907059
[TBL] [Abstract][Full Text] [Related]
43. Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance.
Chou S; Ercolani RJ; Marousek G; Bowlin TL
Antimicrob Agents Chemother; 2013 Jul; 57(7):3375-9. PubMed ID: 23650173
[TBL] [Abstract][Full Text] [Related]
44. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
[TBL] [Abstract][Full Text] [Related]
45. Emergence of multiple human cytomegalovirus ganciclovir-resistant mutants with deletions and substitutions within the UL97 gene in a patient with severe combined immunodeficiency.
Wolf DG; Yaniv I; Ashkenazi S; Honigman A
Antimicrob Agents Chemother; 2001 Feb; 45(2):593-5. PubMed ID: 11158760
[TBL] [Abstract][Full Text] [Related]
46. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
[TBL] [Abstract][Full Text] [Related]
47. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.
Wagner M; Michel D; Schaarschmidt P; Vaida B; Jonjic S; Messerle M; Mertens T; Koszinowski U
J Virol; 2000 Nov; 74(22):10729-36. PubMed ID: 11044117
[TBL] [Abstract][Full Text] [Related]
48. Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
Castor J; Cook L; Corey L; Jerome KR
J Clin Microbiol; 2007 Aug; 45(8):2681-3. PubMed ID: 17537934
[TBL] [Abstract][Full Text] [Related]
49. Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis.
Hu H; Jabs DA; Forman MS; Martin BK; Dunn JP; Weinberg DV; Davis JL;
J Infect Dis; 2002 Apr; 185(7):861-7. PubMed ID: 11920309
[TBL] [Abstract][Full Text] [Related]
50. The human cytomegalovirus UL97 protein is phosphorylated and a component of virions.
van Zeijl M; Fairhurst J; Baum EZ; Sun L; Jones TR
Virology; 1997 Apr; 231(1):72-80. PubMed ID: 9143304
[TBL] [Abstract][Full Text] [Related]
51. Conserved domains and structure prediction of human cytomegalovirus UL27 protein.
Hantz S; Couvreux A; Champier G; Trapes L; Cotin S; Denis F; Bouaziz S; Alain S
Antivir Ther; 2009; 14(5):663-72. PubMed ID: 19704169
[TBL] [Abstract][Full Text] [Related]
52. Human cytomegalovirus (CMV) UL97 D605E mutation has a higher prevalence in infants with primary CMV infection compared with transplant recipients with CMV recurrence.
Sun J; Cao G; Zhang L; Zhang Y; Zhao Z; Hu J; Ji Y
Transplant Proc; 2012 Dec; 44(10):3022-5. PubMed ID: 23195018
[TBL] [Abstract][Full Text] [Related]
53. Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.
Rose J; Emery VC; Kumar D; Asberg A; Hartmann A; Jardine AG; Bignamini AA; Humar A; Neumann AU
PLoS Pathog; 2017 Apr; 13(4):e1006299. PubMed ID: 28406982
[TBL] [Abstract][Full Text] [Related]
54. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.
Baldanti F; Underwood MR; Stanat SC; Biron KK; Chou S; Sarasini A; Silini E; Gerna G
J Virol; 1996 Mar; 70(3):1390-5. PubMed ID: 8627655
[TBL] [Abstract][Full Text] [Related]
55. Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant.
Faizi Khan R; Mori S; Eizuru Y; Kumura Ishii K; Minamishima Y
Antiviral Res; 1998 Dec; 40(1-2):95-103. PubMed ID: 9864050
[TBL] [Abstract][Full Text] [Related]
56. Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.
McGregor A; Choi KY; Cui X; McVoy MA; Schleiss MR
Antiviral Res; 2008 Jun; 78(3):250-9. PubMed ID: 18325607
[TBL] [Abstract][Full Text] [Related]
57. Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene.
Chou S; Van Wechel LC; Lichy HM; Marousek GI
Antimicrob Agents Chemother; 2005 Jul; 49(7):2710-5. PubMed ID: 15980340
[TBL] [Abstract][Full Text] [Related]
58. Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself.
Michel D; Schaarschmidt P; Wunderlich K; Heuschmid M; Simoncini L; Mühlberger D; Zimmermann A; Pavić I; Mertens T
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2105-12. PubMed ID: 9747718
[TBL] [Abstract][Full Text] [Related]
59. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
Jabs DA; Martin BK; Forman MS; Dunn JP; Davis JL; Weinberg DV; Biron KK; Baldanti F;
J Infect Dis; 2001 Jan; 183(2):333-337. PubMed ID: 11120934
[TBL] [Abstract][Full Text] [Related]
60. Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus.
Liu JB; Zhang Z
J Virol Methods; 2008 Apr; 149(1):129-35. PubMed ID: 18280587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
